Tirzepatide Lowers MACE vs Dulaglutide in SURPASS-CVOT Patients With Heart Failure

By

Alberto Castro Molina MD

November 12, 2025

DAPT-MVD: Extended DAPT reduces MACCE in patients with multi-vessel disease after DES

By

Lucas Marinacci MD

November 12, 2025

NOAC Monotherapy Non-Inferior to Combination Therapy for Net Adverse Clinical events in AF Patients Post–DES: ADAPT AF-DES Trial

By

November 11, 2025

Prasugrel Might be a Better Choice than Ticagrelor For DAPT after PCI for Patients with Diabetes and MVD: The TUXEDO-2 Trial

By

November 11, 2025

DAPT-MVD: Extended DAPT reduces MACCE in patients with multi-vessel disease after DES

January 24, 2026

VESALIUS-CV: PCSK9-Inhibitor Evolocumab Reduces MACE for Primary Prevention

January 28, 2026

CLOSURE-AF: Left Atrial Appendage Closure Fails to Achieve Noninferiority to Medical Therapy in AF Patients With High Bleeding Risk

January 28, 2026

HI-PRO Trial: Extended Low-Intensity Apixaban Reduces Recurrent VTE in Patients with Provoked VTE and Enduring Risk Factors

January 28, 2026

LOSE-AF: Weight Loss Alone Does Not Improve AF Symptoms or Burden in Older Adults

January 28, 2026

Interviews

This Week in Medicine: Coronavirus Update with Physicians Throughout the US – Part 4

By

Cardiology Now Media

May 6, 2020

This Week in Medicine: Coronavirus Update with Physicians Throughout the US – Part 3

By

Cardiology Now Media

May 6, 2020

This Week in Medicine: Coronavirus Update with Physicians Throughout the US – Part 2

By

Cardiology Now Media

May 6, 2020